Cargando…
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.
Estimation of FGF-3 oncogene amplification in DNA samples extracted from paraffin embedded sections of 136 ovarian cancer samples was carried out by a quantitative PCR method. The aim of this study was to elucidate a possible association of FGF-3 copy numbers with established prognostic factors such...
Autores principales: | Rosen, A., Sevelda, P., Klein, M., Dobianer, K., Hruza, C., Czerwenka, K., Hanak, H., Vavra, N., Salzer, H., Leodolter, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968420/ https://www.ncbi.nlm.nih.gov/pubmed/8494710 |
Ejemplares similares
-
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
por: Rosen, A. C., et al.
Publicado: (1994) -
Photon detectors with gaseous amplification
por: Vavra, J
Publicado: (1996) -
TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.
por: Medl, M., et al.
Publicado: (1995) -
Inositol transporters AtINT2 and AtINT4 regulate arsenic accumulation in Arabidopsis seeds
por: Duan, Gui-Lan, et al.
Publicado: (2015) -
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
por: Gorski, Justin W., et al.
Publicado: (2020)